BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 26081949)

  • 1. Should we use the shorter Thai-version quality of life and symptoms questionnaires in women with overactive bladder?
    Bunyavejchevin S; Liao L; Lu SH; Choo MS; Rabbani KJ; Havanond P
    J Obstet Gynaecol Res; 2015 Aug; 41(8):1260-5. PubMed ID: 26081949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Psychometric validation of the OAB-V8 and OAB-V3 scales for the screening of patients with probable overactive bladder in the Spanish population].
    Brenes FJ; Angulo JC; Ochayta D; Rejas J; Arumí D; Cañadas A; Lizarraga I
    Med Clin (Barc); 2014 Dec; 143(12):521-9. PubMed ID: 24725856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliability of Thai-Version Overactive Bladder Symptom Scores (OABSS) Questionnaire and the Correlations of OABSS with Voiding Diary, International Prostate Symptom Score (IPSS), and Patient Perception of Bladder Condition (PPBC) Questionnaires.
    Bunyavejchevin S
    J Med Assoc Thai; 2015 Nov; 98(11):1064-74. PubMed ID: 26817176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptom score change and patient versus doctor satisfaction in overactive bladder before and after anti-muscarinic treatment.
    Bunyavejchevin S
    J Obstet Gynaecol Res; 2015 Jun; 41(6):957-61. PubMed ID: 25773663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the 8-item overactive bladder questionnaire (OAB-v8) using item response theory.
    Peterson AC; Sehgal A; Crump RT; Baverstock R; Sutherland JM; Carlson K
    Neurourol Urodyn; 2018 Mar; 37(3):1095-1100. PubMed ID: 28976596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life in patients with overactive bladder: validation and psychometric properties of the Spanish Overactive Bladder Questionnaire-short Form.
    Arlandis S; Ruiz MA; Errando C; Villacampa F; Arumí D; Lizarraga I; Rejas J
    Clin Drug Investig; 2012 Aug; 32(8):523-32. PubMed ID: 22741748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of overactive bladder questionnaire (1-week recall version) in medically complex elderly patients with overactive bladder.
    Barsdorf AI; Carlsson M; Bushmakin AG; Quinn S; Cappelleri JC; Pleil A
    Int Urogynecol J; 2017 Dec; 28(12):1857-1863. PubMed ID: 28378111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of stress urinary incontinence and overactive bladder on quality of life in Thai women attending the urogynecology clinic.
    Wattanayingcharoenchai R; Manonai J; Vannatim N; Saritapirak S; Imsomboon C; Chittacharoen A
    J Med Assoc Thai; 2007 Jan; 90(1):26-31. PubMed ID: 17621729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Test-retest reliability of four questionnaires for patients with overactive bladder: the overactive bladder questionnaire (OAB-q), patient perception of bladder condition (PPBC), urgency questionnaire (UQ), and the primary OAB symptom questionnaire (POSQ).
    Matza LS; Thompson CL; Krasnow J; Brewster-Jordan J; Zyczynski T; Coyne KS
    Neurourol Urodyn; 2005; 24(3):215-25. PubMed ID: 15747340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The validation of the Dutch OAB-q SF: An overactive bladder symptom bother and health-related quality of life short-form questionnaire.
    Groenendijk IM; Scheepe JR; Noordhoff TC; Blok BFM
    Neurourol Urodyn; 2019 Aug; 38(6):1775-1782. PubMed ID: 31215693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychometric validation of the overactive bladder satisfaction with treatment questionnaire (OAB-SAT-q).
    Margolis MK; Fox KM; Cerulli A; Ariely R; Kahler KH; Coyne KS
    Neurourol Urodyn; 2009; 28(5):416-22. PubMed ID: 19030182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of the B-SAQ, OAB-V8 and OAB-V3 questionnaires as screening tools for overactive bladders in clinical practice.
    Angulo JC; Calderín MP; Fernández Y; González M; Gómez E; Herreros MB; Peñasco P; Zapatero M; Dorado JF
    Actas Urol Esp; 2017; 41(6):383-390. PubMed ID: 28268078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Turkish validation of the overactive bladder symptom score (OABSS) and evaluation of mirabegron treatment response.
    Culha MG; Degirmentepe RB; Ozbir S; Cakir SS; Homma Y
    Int Urogynecol J; 2019 Dec; 30(12):2121-2126. PubMed ID: 31332467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychometric evaluation of the Overactive Bladder Questionnaire (OAB-q) for measuring quality of life and clinical implications in Greek patients with overactive bladder.
    Kontogiannis S; Athanasopoulos A; Tsagkarakis M; Kontodimopoulos N
    Int Urogynecol J; 2022 Nov; 33(11):3035-3043. PubMed ID: 34626200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the Croatian Version of the 8-Item Overactive Bladder Questionnaire (OAB-V8).
    Mikuš M; Ostroški M; Beljan P; Karadža M; Dumančić S; Šprem Goldštajn M; Ćorić M; Kalafatić D; Orešković S
    Female Pelvic Med Reconstr Surg; 2021 Nov; 27(11):e687-e690. PubMed ID: 34534199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the Arabic linguistic version of the 8-item overactive bladder questionnaire (OAB-V8).
    Al-Shaiji TF; Alkabbani M; El-Nahas AR; Thahir A; Almutairi MF; Al-Terki A
    Int Urogynecol J; 2019 Dec; 30(12):2153-2156. PubMed ID: 30788523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linguistic validation of the N-QOL (ICIQ), OAB-q (ICIQ), PPBC, OAB-S and ICIQ-MLUTSsex questionnaires in 16 languages.
    McKown S; Abraham L; Coyne K; Gawlicki M; Piault E; Vats V
    Int J Clin Pract; 2010 Nov; 64(12):1643-52. PubMed ID: 20722767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting self-perceived antimuscarinic therapy effectiveness on overactive bladder symptoms using the Overactive Bladder 8-Question Awareness Tool.
    Villacampa F; Ruiz MA; Errando C; Arlandis S; Arumí D; Lizarraga I; Rejas J
    Int Urogynecol J; 2013 Apr; 24(4):573-81. PubMed ID: 23111865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychosocial factors related to the use of InterStim® for the treatment of refractory overactive bladder.
    Levin PJ; Siddiqui NY; Wu JM; Amundsen CL
    Female Pelvic Med Reconstr Surg; 2014; 20(5):272-5. PubMed ID: 25181377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The psychometric validation of the OAB family impact measure (OAB-FIM).
    Coyne KS; Matza LS; Brewster-Jordan J; Thompson C; Bavendam T
    Neurourol Urodyn; 2010 Mar; 29(3):359-69. PubMed ID: 19274760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.